Corcept Therapeutics Incorporated
- CORT
- NASDAQ
- Medical - Pharmaceuticals
- Cortisol Modulation
- Endocrine/Oncology Drugs
$112.10
Today +1.76%Quote Oct 19, 2026, 08:00 PM UTC
+1.64%over the last month
Max drawdown −9.7%From 1-month high −8.1%3 months +17.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Corcept Therapeutics
Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo Park, California, is a pharmaceutical firm dedicated to the discovery, development, and commercialization of treatments for serious metabolic, oncological, and neuropsychiatric disorders across the United States. Its primary commercial offering is Korlym (mifepristone) tablets, an oral medication taken once daily.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
NASDAQ
Employees
730
Founded
1998
Market value
$12.12B
Quote Oct 19
Floor
$104.36
6.9% below price
Resistance
$113.59
1.3% above price
Price vs analyst targets
26 analysts
Lowest target
$50.00Highest target
$165.00
$50.00Highest target
$165.00
- Price $112.10
- Average target $125.33
- Analysts' target range
Analysts' average target sits about 12% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CORTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free